Medtech DEI Experts Talk Shop: ‘It’s Going To Transform Businesses’

An all-female panel of medtech DEI leaders at the LSX Congress USA conference discussed the importance of diversity and inclusion in research, clinical trials, product development and services to advance health equity as well as fundamental business goals.

2023 LSX Boston
• Source: Shutterstock

Sarah Hassaine, ResMed, Inc.’s head of diversity and inclusion, offered a sobering observation during a panel discussion on health equity at the LSX World Congress USA conference in Boston last week.

“Statistics now show that 70% of DEI programs fail,” she said.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diversity & Inclusion

More from ESG